ID
21514
Beschrijving
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Trefwoorden
Versies (5)
- 24-04-17 24-04-17 -
- 25-04-17 25-04-17 -
- 03-05-17 03-05-17 -
- 14-11-18 14-11-18 - Sarah Riepenhausen
- 15-03-21 15-03-21 - Dr. rer. medic Philipp Neuhaus
Geüploaded op
25 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
German Hodgkin Study Group Study HD16/HD17/HD18 Treatment discontinuation form G6AB
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
Beschrijving
Therapieabbruchbogen
Beschrijving
Date of discontinuation
Datatype
date
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0011008
Beschrijving
Reason for discontinuation
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
Beschrijving
Treatment status
Datatype
integer
Alias
- UMLS CUI [1]
- C0749659
Beschrijving
Further documentation
Datatype
text
Alias
- UMLS CUI [1]
- C0175636
Beschrijving
Date of completion
Datatype
date
Alias
- UMLS CUI [1]
- C0011008
Beschrijving
Signature
Datatype
text
Alias
- UMLS CUI [1]
- C1519316
Similar models
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])